DRIVING HEALTHCARE INNOVATION
ONE PATIENT AT A TIME
MISSION
Therasis is a biotechnology start-up. A disruptor. A trailblazer with true innovation. How can a syndrome affecting 30 million worldwide annually have no accurate means of diagnosis? Our modus operandi: to solve that.
TECHNOLOGY
The combination of a low-cost pre-impregnated swab, tube containing testing fluid, and proprietary machine designed to provide the most accurate readings quickly, Therasis has industry-leading cutting edge tech like no other.
CORPORATE
Our leadership comprises individuals with expertise in biochemistry, medicine, finance, and business. With a combined 50 years' experience in their respective fields, this company is guaranteed to deliver results.
ABOUT US
Therasis is a unicorn dedicated to eradicating sepsis mortality worldwide through the development of a cheap, simple, easy, and accurate method of detection. This enables clinicians to make better decisions and give patients superior healthcare at point of service.
Through the development of a novel gene construct using synthetic biology technology, we're confident we've achieved this. Click below to explore our product, SepDetect.
CONTACT US
University College London
Gower Street
Bloomsbury
WC1E 6BT